Verrica Pharmaceuticals Non-GAAP EPS of $0.25 beats by $1.08, revenue of $12.7M

* Verrica Pharmaceuticals press release [https://seekingalpha.com/pr/20198555-verrica-pharmaceuticals-reports-second-quarter-2025-financial-results] (NASDAQ:VRCA [https://seekingalpha.com/symbol/VRCA]): Q2 Non-GAAP EPS of $0.25 beats by $1.08.
* Revenue of $12.7M (+148.0% Y/Y).

MORE ON VERRICA PHARMACEUTICALS

* Verrica Pharmaceuticals reports 13,434 YCANTH dispensed applicator units in Q2 [https://seekingalpha.com/news/4466108-verrica-pharmaceuticals-reports-13434-ycanth-dispensed-applicator-units-in-q2]
* Seeking Alpha’s Quant Rating on Verrica Pharmaceuticals [https://seekingalpha.com/symbol/VRCA/ratings/quant-ratings]
* Historical earnings data for Verrica Pharmaceuticals [https://seekingalpha.com/symbol/VRCA/earnings]
* Financial information for Verrica Pharmaceuticals [https://seekingalpha.com/symbol/VRCA/income-statement]